SUMMARY Three hundred and eleven patients with classical or definite rheumatoid arthritis were observed over an 11-year period. This group is of particular interest since 214 patients were given cytotoxic therapy, 203 were treated with azathioprine (52 of these also received chlorambucil or cyclophosphamide), and 11 were treated with cyclophosphamide or chlorambucil alone. Forty-six patients died. This is an excess mortality compared with the expected rate for the general population matched with respect to age and sex. The death rate was higher than expected in the age group 45-64 years but lower in those aged 75 years or over. There were more deaths from neoplasia and ischaemic heart disease in the younger age group. One patient died of lymphosarcoma; treatment had been with corticosteroids, gold, and chloroquine. No other tumours of the reticuloendothelial system were recorded, and no patient developed leukaemia.
Several controlled studies have demonstrated suppression of disease activity in rheumatoid arthritis by azathioprine.'-' Since this treatment does not produce a lasting remission, long-term administration would be expected in many instances. This focuses attention on the adverse effects of prolonged administration of azathioprine, including bone marrow suppression, susceptibility to infection, and the potential development of malignant tumours.
The cause of death in patients with rheumatoid arthritis has been assessed both by surveys based on clinical populations and by reviews of necropsy records.4-1" There have been few attempts to assess the influence of drug therapy on mortality or the incidence of neoplasia.
The patients in this study are unusual in that treatment with azathioprine was commenced in some patients as long as 11 years ago, often in high dosage, 5 mg kg/day, and sodium aurothiomalate has been given in combination.
In view of the observed increased frequency of lymphoreticular neoplasm arising in recipients treated transiently with immunosuppressive drugs '2 13 this study has set out to assess the incidence of the type of tumour and other neoplasms in a closely surveyed group of rheumatoid patients.
For purposes of comparison an analysis of The tumours diagnosed in both the deceased and the survivors is recorded in Table 1 . Five patients have had apparently successful treatment of their neoplasm (3 patients had received cytotoxic therapy before the discovery of the neoplasia). Ten of the 20 neoplasms were in patients who were receiving cytotoxic therapy (Table 2 ). There is no reason to link rheumatoid arthritis with any particular form of tumour. The 1 case of lymphosarcoma occurred in a 71-year-old patient with no evidence of Sjogren's syndrome who had not received cytotoxic therapy.
Principal causes of death are listed (Table 3) . Ischaemic heart disease heads the list followed by neoplasia. Deaths due to infections all involved the lung, and the incidence is lower than previously recorded in patients with rheumatoid arthritis.7 14 The observed death rate from all causes according to age has been compared by the chi-square test (Table 4 ). There is good agreement, however, between observed and expected values for each chosen interval of follow-up ( Table 5 ).
The observed and expected deaths during the years of the study are shown. There is a progressive decline in patients dying of ischaemic heart disease at each interval of follow-up but the number of cases in this analysis is insufficient to allow statistical evaluation. There is no change in the number of deaths from malignancy.
Analysis of age-related specific causes of death (Table 6) showed an increased frequency of deaths due to neoplasia and ischaemic heart disease occurring in the 45-64 year old age group, but this is not significant.
Discussion
Most surveys of the causes of death in rheumatoid arthritis agree that patients with the disease have a higher mortality rate than the rest of the population, though they die not so much from specific complications of the disease as from all the usual causes of death at an earlier age than usual. Evidence is accumulating to suggest that lymphoreticular tumours may be associated withautoimmune disease.24-27 Patients with Sj6gren's syndrome are especially prone to develop extensive lymphocyte infiltrates in extrasalivary organs with pseudolymphoma formation and occasional progression to malignant lymphoma. 27 An increased incidence of malignant neoplasm has been reported in transplant recipients in whom neoplasia was incidental to the transplant procedure. ' 
